These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 26365032)
1. Selective antagonization of activated Nrf2 and inhibition of cancer cell proliferation by procyanidins from Cinnamomi Cortex extract. Ohnuma T; Anzai E; Suzuki Y; Shimoda M; Saito S; Nishiyama T; Ogura K; Hiratsuka A Arch Biochem Biophys; 2015 Nov; 585():17-24. PubMed ID: 26365032 [TBL] [Abstract][Full Text] [Related]
2. Procyanidins from Cinnamomi Cortex promote proteasome-independent degradation of nuclear Nrf2 through phosphorylation of insulin-like growth factor-1 receptor in A549 cells. Ohnuma T; Sakamoto K; Shinoda A; Takagi C; Ohno S; Nishiyama T; Ogura K; Hiratsuka A Arch Biochem Biophys; 2017 Dec; 635():66-73. PubMed ID: 29051069 [TBL] [Abstract][Full Text] [Related]
3. Enhanced sensitivity of A549 cells to the cytotoxic action of anticancer drugs via suppression of Nrf2 by procyanidins from Cinnamomi Cortex extract. Ohnuma T; Matsumoto T; Itoi A; Kawana A; Nishiyama T; Ogura K; Hiratsuka A Biochem Biophys Res Commun; 2011 Oct; 413(4):623-9. PubMed ID: 21925486 [TBL] [Abstract][Full Text] [Related]
4. Oligomeric proanthocyanidins protects A549 cells against H2O2-induced oxidative stress via the Nrf2-ARE pathway. Sun C; Jin W; Shi H Int J Mol Med; 2017 Jun; 39(6):1548-1554. PubMed ID: 28487966 [TBL] [Abstract][Full Text] [Related]
5. Suppression of Nrf2 Activity by Chestnut Leaf Extract Increases Chemosensitivity of Breast Cancer Stem Cells to Paclitaxel. Woo Y; Oh J; Kim JS Nutrients; 2017 Jul; 9(7):. PubMed ID: 28718813 [TBL] [Abstract][Full Text] [Related]
6. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Homma S; Ishii Y; Morishima Y; Yamadori T; Matsuno Y; Haraguchi N; Kikuchi N; Satoh H; Sakamoto T; Hizawa N; Itoh K; Yamamoto M Clin Cancer Res; 2009 May; 15(10):3423-32. PubMed ID: 19417020 [TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers. Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257 [TBL] [Abstract][Full Text] [Related]
8. Procyanidin C1 from Cinnamomi Cortex inhibits TGF-β-induced epithelial-to-mesenchymal transition in the A549 lung cancer cell line. Kin R; Kato S; Kaneto N; Sakurai H; Hayakawa Y; Li F; Tanaka K; Saiki I; Yokoyama S Int J Oncol; 2013 Dec; 43(6):1901-6. PubMed ID: 24141365 [TBL] [Abstract][Full Text] [Related]
9. Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs. Tang X; Wang H; Fan L; Wu X; Xin A; Ren H; Wang XJ Free Radic Biol Med; 2011 Jun; 50(11):1599-609. PubMed ID: 21402146 [TBL] [Abstract][Full Text] [Related]
10. Lotus seed skin proanthocyanidin extract exhibits potent antioxidant property via activation of the Nrf2-ARE pathway. Li T; Li Q; Wu W; Li Y; Hou DX; Xu H; Zheng B; Zeng S; Shan Y; Lu X; Deng F; Qin S Acta Biochim Biophys Sin (Shanghai); 2019 Jan; 51(1):31-40. PubMed ID: 30544155 [TBL] [Abstract][Full Text] [Related]
11. Coroglaucigenin enhances the radiosensitivity of human lung cancer cells through Nrf2/ROS pathway. Sun M; Pan D; Chen Y; Li Y; Gao K; Hu B Oncotarget; 2017 May; 8(20):32807-32820. PubMed ID: 28415625 [TBL] [Abstract][Full Text] [Related]
12. Screening active components of modified Xiaoyao powder as NRF2 agonists. Yang Y; Wang Y; Wang T; Jiang X; Wang L Cell Biochem Funct; 2017 Dec; 35(8):518-526. PubMed ID: 29214656 [TBL] [Abstract][Full Text] [Related]
13. Cytoprotective effect of bioactive sea buckthorn extract on paraquat-exposed A549 cells via induction of Nrf2 and its downstream genes. Podder B; Kim YS; Song HY Mol Med Rep; 2013 Dec; 8(6):1852-60. PubMed ID: 24141985 [TBL] [Abstract][Full Text] [Related]
14. Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model. Ji XJ; Chen SH; Zhu L; Pan H; Zhou Y; Li W; You WC; Gao CC; Zhu JH; Jiang K; Wang HD Oncol Rep; 2013 Jul; 30(1):157-64. PubMed ID: 23673813 [TBL] [Abstract][Full Text] [Related]
15. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer. Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204 [TBL] [Abstract][Full Text] [Related]
16. Identification of Carpesium cernuum extract as a tumor migration inhibitor based on its biological response profiling in breast cancer cells. Dang H; Li H; Ma C; Wang Y; Tian J; Deng L; Wang D; Jing X; Luo K; Xing W; Cheng J; Guo H; Xie L Phytomedicine; 2019 Nov; 64():153072. PubMed ID: 31480012 [TBL] [Abstract][Full Text] [Related]
17. Grape-seed procyanidins inhibit the in vitro growth and invasion of pancreatic carcinoma cells. Chung YC; Huang CC; Chen CH; Chiang HC; Chen KB; Chen YJ; Liu CL; Chuang LT; Liu M; Hsu CP Pancreas; 2012 Apr; 41(3):447-54. PubMed ID: 22015975 [TBL] [Abstract][Full Text] [Related]
18. Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression. Chen B; Zhang Y; Wang Y; Rao J; Jiang X; Xu Z J Steroid Biochem Mol Biol; 2014 Sep; 143():11-8. PubMed ID: 24486718 [TBL] [Abstract][Full Text] [Related]
19. Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification. Wu YS; Looi CY; Subramaniam KS; Masamune A; Chung I Oncotarget; 2016 Jun; 7(24):36719-36732. PubMed ID: 27167341 [TBL] [Abstract][Full Text] [Related]
20. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1. Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]